Xembify

(immune globulin subcutaneous (human) - klhw)
Check Coverage Restrictions
Or select your Insurance from the list below:

Dosage & Administration

For subcutaneous infusion only

Dose ( 2.1)
XEMBIFY can be administered at regular intervals from daily up to every two weeks (biweekly).

Administration
Infusion sites: up to 6 infusion sites simultaneously, with at least 2 inches (5 cm) between sites avoiding bony prominences, visible blood vessels, scars, and any areas of inflammation (irritation) or infection.  Rotate sites for each administration.

Patient Age Maximum Volume
(mL/infusion site)
Infusion Rate
(mL/hr/infusion site)
Children 2 to <10 years 25 ≤25
Adults, children ≥10 years 25 ≤35

Xembify Prescribing Information

Xembify Prior Authorization Resources

Benefits investigation

Xembify PubMed™ News

    Xembify Patient Education

    Getting started on Xembify

    Patient toolkit